{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:01:38Z","timestamp":1781784098692,"version":"3.54.5"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010201","name":"Department of Science and Technology, Government of Rajasthan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010201","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jneuroim.2021.577501","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T21:41:28Z","timestamp":1611783688000},"page":"577501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders"],"prefix":"10.1016","volume":"353","author":[{"given":"Durga Shankar","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Paddibhatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Raghuwanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Malleswarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sangeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narasaiah","family":"Kovuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Dahariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dushyant Kumar","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Pallepati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Kumar","family":"Gutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.jneuroim.2021.577501_bb0005","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.3233\/JAD-2010-100465","article-title":"Calcium and mitochondrial reactive oxygen species generation: how to read the facts","volume":"20","author":"Adam-Vizi","year":"2010","journal-title":"J. Alzheimer\u2019s Dis.: JAD"},{"issue":"12","key":"10.1016\/j.jneuroim.2021.577501_bb0010","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s00125-010-1894-6","article-title":"Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age","volume":"53","author":"Agudo","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jneuroim.2021.577501_bb0015","series-title":"Cannabinoids in Health and Disease. Book chapter-3","article-title":"The potential therapeutic role of the cannabinoid system in neurological disorders of the basal Ganglia: An overview","author":"Aguilera","year":"2016"},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577501_bb0020","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/cr0782067","article-title":"Enzymatic pathways that regulate endocannabinoid signaling in the nervous system","volume":"108","author":"Ahn","year":"2008","journal-title":"Chem. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2021.577501_bb0025","first-page":"S17","article-title":"The Concise Guide to Pharmacology 2017\/18: G protein-coupled receptors","volume":"174","author":"Alexander","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/ijms21041283","article-title":"Cannabinoid-mediated modulation of oxidative stress and early inflammatory response after hypoxia-ischemia","volume":"21","author":"Alonso-Alconada","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2016.12.009","article-title":"Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis","volume":"303","author":"Annunziata","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0269881105051541","article-title":"Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential","volume":"19","author":"Ashton","year":"2005","journal-title":"J. Psychopharmacol. (Oxford, Engl.)"},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0045","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuropharm.2012.04.024","article-title":"CB\u2082 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons","volume":"63","author":"Atwood","year":"2012","journal-title":"Neuropharmacology"},{"issue":"6773","key":"10.1016\/j.jneuroim.2021.577501_bb0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35003583","article-title":"Cannabinoids control spasticity and tremor in a multiple sclerosis model","volume":"404","author":"Baker","year":"2000","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jneuroim.2021.577501_bb0055","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bbalip.2010.06.006","article-title":"Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties","volume":"1801","author":"Balvers","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"issue":"1-2","key":"10.1016\/j.jneuroim.2021.577501_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2006.02.001","article-title":"Cannabinoids in medicine: a review of their therapeutic potential","volume":"105","author":"Ben","year":"2006","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.jneuroim.2021.577501_bb0070","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1159\/000110714","article-title":"Effect of anandamide on erythrocyte survival","volume":"20","author":"Bentzen","year":"2007","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.200305129","article-title":"Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain","volume":"163","author":"Bisogno","year":"2003","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.jneuroim.2021.577501_bb0080","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.jneuroim.2021.577501_bb0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"Pt 1","key":"10.1016\/j.jneuroim.2021.577501_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Bl\u00e1zquez","year":"2011","journal-title":"Brain J. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000320559","article-title":"Effect of anandamide in Plasmodium Berghei-infected mice","volume":"26","author":"Bobbala","year":"2010","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0100","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1432-1033.1996.0704p.x","article-title":"Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression","volume":"237","author":"Bouaboula","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.coi.2007.04.015","article-title":"Cytokines and T-cell homeostasis","volume":"19","author":"Boyman","year":"2007","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/09537104.2013.803530","article-title":"Mechanism of platelet activation induced by endocannabinoids in blood and plasma","volume":"25","author":"Brantl","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.jneuroim.2021.577501_bb0115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbi.2017.10.021","article-title":"Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization","volume":"68","author":"Braun","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.jneuroim.2021.577501_bb0120","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/carcin\/bgq151","article-title":"Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines","volume":"31","author":"Brown","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jneuroim.2021.577501_bb0125","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1567-5769(01)00147-3","article-title":"Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation","volume":"2","author":"Carlisle","year":"2002","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008688","article-title":"Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors","volume":"5","author":"Cencioni","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/can.2016.0002","article-title":"Endocannabinoids and Immunity","volume":"1","author":"Chiurchi\u00f9","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577501_bb0145","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ana.23875","article-title":"Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis","volume":"73","author":"Chiurchi\u00f9","year":"2013","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/imm.12441","article-title":"Endocannabinoid signalling in innate and adaptive immunity","volume":"144","author":"Chiurchi\u00f9","year":"2015","journal-title":"Immunology"},{"issue":"Pt A","key":"10.1016\/j.jneuroim.2021.577501_bb0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2016.09.003","article-title":"Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors","volume":"113","author":"Chiurchi\u00f9","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.jneuroim.2021.577501_bb0160","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1096\/fj.201800107R","article-title":"Bioactive lipids ALIAmides differentially modulate inflammatory responses of distinct subsets of primary human T lymphocytes","volume":"32","author":"Chiurchi\u00f9","year":"2018","journal-title":"FASEB J.: Off. Publ. Feder. Am. Soc. Exp. Biol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0165","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.intimp.2006.11.008","article-title":"Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis","volume":"7","author":"Coopman","year":"2007","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.jneuroim.2021.577501_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108282","article-title":"Endocannabinoids control platelet activation and limit aggregate formation under flow","volume":"9","author":"De Angelis","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jneuroim.2021.577501_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028159","article-title":"Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis","volume":"6","author":"De Filippis","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0185","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1192\/bjp.bp.108.056952","article-title":"Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia","volume":"196","author":"Degenhardt","year":"2010","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0190","doi-asserted-by":"crossref","DOI":"10.1213\/01.ANE.0000131505.03006.74","article-title":"The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets","volume":"99","author":"Deusch","year":"2004","journal-title":"Anesth. Analg."},{"issue":"5090","key":"10.1016\/j.jneuroim.2021.577501_bb0195","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0200","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s13311-015-0388-0","article-title":"Cannabinoids in the treatment of neurological disorders","volume":"12","author":"Devinsky","year":"2015","journal-title":"Neurotherap. J. Am. Soc. Exp. Neuro Therap."},{"issue":"18","key":"10.1016\/j.jneuroim.2021.577501_bb0205","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s40265-017-0835-9","article-title":"Tofacitinib: a review in rheumatoid arthritis","volume":"77","author":"Dhillon","year":"2017","journal-title":"Drugs"},{"issue":"14","key":"10.1016\/j.jneuroim.2021.577501_bb0210","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2174\/092986710790980078","article-title":"Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs","volume":"17","author":"Di Marzo","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"6507","key":"10.1016\/j.jneuroim.2021.577501_bb0215","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signalling and the deteriorating brain","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0230","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/cne.21568","article-title":"Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules","volume":"506","author":"Egertov\u00e1","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-2-29","article-title":"Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation","volume":"2","author":"Ehrhart","year":"2005","journal-title":"J. Neuroinflammation"},{"issue":"1407","key":"10.1016\/j.jneuroim.2021.577501_bb0240","first-page":"381","article-title":"The neurobiology and evolution of cannabinoid signalling","volume":"356","author":"Elphick","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.1989.tb22596.x","article-title":"Isolation, characterization, and regulation of diacylglycerol lipases from the bovine brain","volume":"559","author":"Farooqui","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0250","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.jneuroim.2021.577501_bb0255","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1476-5381.2008.00088.x","article-title":"The endocannabinoid system as a target for the treatment of motor dysfunction","volume":"156","author":"Fern\u00e1ndez-Ruiz","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"2-3","key":"10.1016\/j.jneuroim.2021.577501_bb0260","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0014-5793(02)02341-4","article-title":"Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues","volume":"513","author":"Fezza","year":"2002","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.jneuroim.2021.577501_bb0265","doi-asserted-by":"crossref","first-page":"17078","DOI":"10.3390\/molecules191117078","article-title":"Endocannabinoids, related compounds and their metabolic routes","volume":"19","author":"Fezza","year":"2014","journal-title":"Mol. (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1874473710902010051","article-title":"Phytocannabinoids and endocannabinoids","volume":"2","author":"Fisar","year":"2009","journal-title":"Curr. Drug Abuse Rev."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Gali\u00e8gue","year":"1995","journal-title":"Eur. J. Biochem."},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0280","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.plipres.2013.05.004","article-title":"Cannabinoid receptor signaling in progenitor\/stem cell proliferation and differentiation","volume":"52","author":"Galve-Roperh","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"24","key":"10.1016\/j.jneuroim.2021.577501_bb0285","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.4161\/15384101.2014.982941","article-title":"2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts","volume":"13","author":"Gasperi","year":"2014","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"key":"10.1016\/j.jneuroim.2021.577501_bb0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biocel.2014.03.028","article-title":"2-Arachidonoylglycerol modulates human endothelial cell\/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors","volume":"51","author":"Gasperi","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"17","key":"10.1016\/j.jneuroim.2021.577501_bb0295","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s00018-015-1924-0","article-title":"Downstream effects of endocannabinoid on blood cells: implications for health and disease","volume":"72","author":"Gasperi","year":"2015","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0300","first-page":"559","article-title":"Delta-9 -tetrahydrocannabinol and decreased macrophage migration inhibition activity","volume":"10","author":"Gaul","year":"1975","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0305","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/nan.12569","article-title":"Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons","volume":"46","author":"Gentile","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0310","first-page":"137","article-title":"Endocannabinoids receptors mediated central and peripheral effects (review)","volume":"298","author":"Ghonghadze","year":"2020","journal-title":"Georgian Med. News"},{"issue":"14","key":"10.1016\/j.jneuroim.2021.577501_bb0315","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.molimm.2006.01.005","article-title":"Cannabinoid receptor CB2 modulates the CXCL12\/CXCR4-mediated chemotaxis of T lymphocytes","volume":"43","author":"Ghosh","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0320","doi-asserted-by":"crossref","first-page":"796715","DOI":"10.1155\/2013\/796715","article-title":"The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health","volume":"2013","author":"Gowran","year":"2013","journal-title":"Stem Cells Int."},{"issue":"29-30","key":"10.1016\/j.jneuroim.2021.577501_bb0325","first-page":"495","article-title":"The therapeutic potential of cannabis and cannabinoids","volume":"109","author":"Grotenhermen","year":"2012","journal-title":"Deutsches Arzteblatt Int."},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0335","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/YCO.0b013e32812144cc","article-title":"Prevalence and correlates of cannabis use in developed and developing countries","volume":"20","author":"Hall","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0350","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2005.01.004","article-title":"Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal","volume":"45","author":"Hashimotodani","year":"2005","journal-title":"Neuron"},{"issue":"16","key":"10.1016\/j.jneuroim.2021.577501_bb0355","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2174\/1389450117666160112113703","article-title":"The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions","volume":"17","author":"Haugh","year":"2016","journal-title":"Curr. Drug Targets"},{"issue":"20","key":"10.1016\/j.jneuroim.2021.577501_bb0365","doi-asserted-by":"crossref","first-page":"9574","DOI":"10.1073\/pnas.91.20.9574","article-title":"Identification of a phosphatidic acid-preferring phospholipase A1 from bovine brain and testis","volume":"91","author":"Higgs","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0370","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2011.09.002","article-title":"Phytocannabinoids as novel therapeutic agents in CNS disorders","volume":"133","author":"Hill","year":"2012","journal-title":"Pharmacol. Therap."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0375","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/can.2017.0017","article-title":"Cannabis and pain: a clinical review","volume":"2","author":"Hill","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"issue":"12","key":"10.1016\/j.jneuroim.2021.577501_bb0380","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1242\/bio.20149571","article-title":"TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation","volume":"3","author":"Hofmann","year":"2014","journal-title":"Biol. Open"},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0385","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajpath.2011.11.003","article-title":"The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications","volume":"180","author":"Horv\u00e1th","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"6 Pt B","key":"10.1016\/j.jneuroim.2021.577501_bb0390","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/nbdi.1998.0215","article-title":"The CB1 cannabinoid receptor in the brain","volume":"5","author":"Howlett","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0395","first-page":"169","article-title":"CB1 and CB2 receptor pharmacology","volume":"80","author":"Howlett","year":"2017","journal-title":"Adv. Pharmacol. (San Diego, Calif.)"},{"issue":"14","key":"10.1016\/j.jneuroim.2021.577501_bb0400","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2174\/092986710790980023","article-title":"CB(1) cannabinoid receptors and their associated proteins","volume":"17","author":"Howlett","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"46","key":"10.1016\/j.jneuroim.2021.577501_bb0405","doi-asserted-by":"crossref","first-page":"42639","DOI":"10.1074\/jbc.M107351200","article-title":"Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain","volume":"276","author":"Huang","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jneuroim.2021.577501_bb0410","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1528-1157.2002.29101.x","article-title":"Pentylenetetrazol-induced recurrent seizures in rat pups: time course on spatial learning and long-term effects","volume":"43","author":"Huang","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2021.577501_bb0415","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","article-title":"Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders","volume":"62","author":"Iannotti","year":"2016","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0420","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/can.2016.0037","article-title":"Cannabinoid CB1 and CB2 receptor signaling and bias","volume":"2","author":"Ibsen","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"issue":"7","key":"10.1016\/j.jneuroim.2021.577501_bb0425","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm1255","article-title":"Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors","volume":"11","author":"Idris","year":"2005","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.jneuroim.2021.577501_bb0430","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1210\/en.2008-0150","article-title":"Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor","volume":"149","author":"Idris","year":"2008","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0435","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cmet.2009.07.006","article-title":"Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells","volume":"10","author":"Idris","year":"2009","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0440","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00065.x","article-title":"Cannabidiol: a promising drug for neurodegenerative disorders?","volume":"15","author":"Iuvone","year":"2009","journal-title":"CNS Neurosci. Therap."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0445","article-title":"The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair","author":"Jehle","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0450","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrc2804","article-title":"Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer","volume":"10","author":"Jenq","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.jneuroim.2021.577501_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000641","article-title":"Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells","volume":"2","author":"Jiang","year":"2007","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577501_bb0460","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.seizure.2012.03.001","article-title":"Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures","volume":"21","author":"Jones","year":"2012","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.jneuroim.2021.577501_bb0465","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2183\/pjab.90.235","article-title":"Control of synaptic function by endocannabinoid-mediated retrograde signaling","volume":"90","author":"Kano","year":"2014","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"29","key":"10.1016\/j.jneuroim.2021.577501_bb0470","doi-asserted-by":"crossref","first-page":"17287","DOI":"10.1074\/jbc.271.29.17287","article-title":"Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue","volume":"271","author":"Kempe","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0475","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2125.2010.03697.x","article-title":"2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors","volume":"70","author":"Keown","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0480","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1042\/BJ20102118","article-title":"N-Docosahexaenoylethanolamide promotes development of hippocampal neurons","volume":"435","author":"Kim","year":"2011","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0485","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pbb.2011.06.022","article-title":"Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice","volume":"99","author":"Kinsey","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577501_bb0490","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0495","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-0-387-72005-0_43","article-title":"Therapeutic potential of cannabinoid-based drugs","volume":"601","author":"Klein","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2013.11.002","article-title":"Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS","volume":"287","author":"Kong","year":"2014","journal-title":"Cell. Immunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0505","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s13311-015-0376-4","article-title":"Cannabis in the treatment of dystonia, dyskinesias, and tics","volume":"12","author":"Koppel","year":"2015","journal-title":"Neurotherapeutics: J. Am. Soc. Exp. NeuroTherapeutics"},{"issue":"6","key":"10.1016\/j.jneuroim.2021.577501_bb0510","first-page":"C1553","article-title":"Role of Ca2+-activated K+ channels in human erythrocyte apoptosis","volume":"285","author":"Lang","year":"2003","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"30","key":"10.1016\/j.jneuroim.2021.577501_bb0515","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.2174\/092986706779026156","article-title":"An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments","volume":"13","author":"Lastres-Becker","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0520","doi-asserted-by":"crossref","first-page":"13123","DOI":"10.1038\/ncomms13123","article-title":"Orphan GPR110 (ADGRF1) targeted by N-docosahexaenoylethanolamine in development of neurons and cognitive function","volume":"7","author":"Lee","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0525","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0530","doi-asserted-by":"crossref","first-page":"150276","DOI":"10.1098\/rsob.150276","article-title":"Modulation of cellular redox homeostasis by the endocannabinoid system","volume":"6","author":"Lipina","year":"2016","journal-title":"Open Biol."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2007.05.020","article-title":"Multiple pathways involved in the biosynthesis of anandamide","volume":"54","author":"Liu","year":"2008","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577501_bb0540","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1601-183X.2009.00498.x","article-title":"Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands","volume":"8","author":"Liu","year":"2009","journal-title":"Genes Brain Behav."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0545","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/jpet.109.156216","article-title":"Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons","volume":"331","author":"Liu","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0550","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/BOR.0000000000000590","article-title":"Joints for joints: cannabinoids in the treatment of rheumatoid arthritis","volume":"31","author":"Lowin","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2-3","key":"10.1016\/j.jneuroim.2021.577501_bb0555","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1054\/plef.2001.0342","article-title":"Molecular biology of cannabinoid receptors","volume":"66","author":"Lutz","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"2\u20133","key":"10.1016\/j.jneuroim.2021.577501_bb0560","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-5793(99)00308-7","article-title":"Anandamide activates human platelets through a pathway independent of the arachidonate cascade","volume":"447","author":"Maccarrone","year":"1999","journal-title":"FEBS Lett."},{"issue":"29","key":"10.1016\/j.jneuroim.2021.577501_bb0565","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1523\/JNEUROSCI.0945-05.2005","article-title":"Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum","volume":"25","author":"Maejima","year":"2005","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577501_bb0570","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1055\/s-0037-1614296","article-title":"Morphological evidence that 2-arachidonoylglycerol is a true agonist of human platelets","volume":"92","author":"Malorni","year":"2004","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0575","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm1561","article-title":"Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells","volume":"13","author":"Maresz","year":"2007","journal-title":"Nat. Med."},{"issue":"1-2","key":"10.1016\/j.jneuroim.2021.577501_bb0580","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-5728(98)00177-5","article-title":"Immune function alterations in mice tolerant to delta9-tetrahydrocannabinol: functional and biochemical parameters","volume":"92","author":"Massi","year":"1998","journal-title":"J. Neuroimmunol."},{"issue":"30","key":"10.1016\/j.jneuroim.2021.577501_bb0590","doi-asserted-by":"crossref","first-page":"E6034","DOI":"10.1073\/pnas.1610325114","article-title":"Anti-inflammatory \u03c9-3 endocannabinoid epoxides","volume":"114","author":"McDougle","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0600","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bcp.2018.08.037","article-title":"Gut microbiota, cannabinoid system and neuroimmune interactions: new perspectives in multiple sclerosis","volume":"157","author":"Mestre","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.jneuroim.2021.577501_bb0605","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.2017.8334","article-title":"Clinicopathological evaluation of chronic traumatic encephalopathy in players of american football","volume":"318","author":"Mez","year":"2017","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jneuroim.2021.577501_bb0610","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1523\/JNEUROSCI.22-22-09742.2002","article-title":"Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase\/Akt signaling","volume":"22","author":"Molina-Holgado","year":"2002","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0615","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/can.2017.0036","article-title":"An update on non-CB1, Non-CB2 cannabinoid related G-protein-coupled receptors","volume":"2","author":"Morales","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0620","first-page":"103","article-title":"Molecular targets of the phytocannabinoids: a complex picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"issue":"6820","key":"10.1016\/j.jneuroim.2021.577501_bb0625","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/35054550","article-title":"Molecular phylogenetics and the origins of placental mammals","volume":"409","author":"Murphy","year":"2001","journal-title":"Nature"},{"issue":"4\u20136","key":"10.1016\/j.jneuroim.2021.577501_bb0630","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000080333","article-title":"Cl- channel blockers NPPB and niflumic acid blunt Ca(2+)-induced erythrocyte \u2018apoptosis\u2019","volume":"14","author":"Myssina","year":"2004","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0635","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0003-9861(02)00038-3","article-title":"2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain","volume":"402","author":"Nakane","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0640","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes","volume":"9","author":"Navarro","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0645","series-title":"Cannabis: our position for a Canadian Public Policy. Report of the Senate Special Committee on Illegal Drugs","first-page":"706","author":"Nolin","year":"2002"},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0655","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1124\/jpet.111.182717","article-title":"Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model","volume":"338","author":"Pandey","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0660","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1476-5381.2010.00775.x","article-title":"Animal models of cannabinoid reward","volume":"160","author":"Panlilio","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1-3","key":"10.1016\/j.jneuroim.2021.577501_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2008.05.002","article-title":"Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation","volume":"595","author":"Patinkin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.jneuroim.2021.577501_bb0670","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","article-title":"Pharmacology of cannabinoid receptor ligands","volume":"6","author":"Pertwee","year":"1999","journal-title":"Curr. Med. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2021.577501_bb0675","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.ijo.0803272","article-title":"The pharmacology of cannabinoid receptors and their ligands: an overview","volume":"30","author":"Pertwee","year":"2006","journal-title":"Int. J. Obes. (2005)"},{"issue":"2\u20133","key":"10.1016\/j.jneuroim.2021.577501_bb0680","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukotrienes Essent. Fatty Acids"},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0685","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb2000","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"British journal of pharmacology"},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0690","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cbpa.2009.04.616","article-title":"Endocannabinoid chemical biology: a tool for the development of novel therapies","volume":"13","author":"Petrosino","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577501_bb0695","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tips.2013.03.003","article-title":"The endocannabinoid signaling system in cancer","volume":"34","author":"Pisanti","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0700","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","article-title":"Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor","volume":"301","author":"Porter","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0705","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11481-007-9077-z","article-title":"The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES\/CCL5: linkage to the CB2 receptor","volume":"3","author":"Raborn","year":"2008","journal-title":"J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol."},{"issue":"8","key":"10.1016\/j.jneuroim.2021.577501_bb0710","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577501_bb0715","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bjp.0707420","article-title":"Endocannabinoids and the haematological system","volume":"152","author":"Randall","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.jneuroim.2021.577501_bb0720","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11910-018-0859-x","article-title":"Cannabinoids for treatment of MS symptoms: state of the evidence","volume":"18","author":"Rice","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"13","key":"10.1016\/j.jneuroim.2021.577501_bb0725","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.2174\/13816128113199990427","article-title":"Cannabinoids and schizophrenia: therapeutic prospects","volume":"20","author":"Robson","year":"2014","journal-title":"Curr. Pharm. Design"},{"issue":"Pt B","key":"10.1016\/j.jneuroim.2021.577501_bb0730","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.yebeh.2016.11.006","article-title":"Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection","volume":"70","author":"Rosenberg","year":"2017","journal-title":"Epilepsy Behav.: E&B"},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0735","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.expneurol.2010.03.030","article-title":"The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis","volume":"224","author":"Rossi","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0740","article-title":"The immunosuppressive effect of the endocannabinoid system on the inflammatory phenotypes of macrophages and mesenchymal stromal cells: a comparative study","author":"Ruhl","year":"2020","journal-title":"Pharmacol. Rep.: PR"},{"issue":"8","key":"10.1016\/j.jneuroim.2021.577501_bb0750","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/cbdv.200790144","article-title":"History of cannabis and its preparations in saga, science, and sobriquet","volume":"4","author":"Russo","year":"2007","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0755","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/TCRM.S1928","article-title":"Cannabinoids in the management of difficult to treat pain","volume":"4","author":"Russo","year":"2008","journal-title":"Therapeutics Clin. Risk Manag."},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0760","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(00)00307-6","article-title":"In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors","volume":"109","author":"Sacerdote","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.jneuroim.2021.577501_bb0765","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.4049\/jimmunol.170.10.4953","article-title":"Differential roles of CB1 and CB2 cannabinoid receptors in mast cells","volume":"170","author":"Samson","year":"2003","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0770","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(98)01085-0","article-title":"Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells","volume":"436","author":"S\u00e1nchez","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0775","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fnbeh.2015.00347","article-title":"Epigenetic alterations in Alzheimer\u2019s disease","volume":"9","author":"Sanchez-Mut","year":"2015","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0780","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/taap.1996.8034","article-title":"Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system","volume":"142","author":"Schatz","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0785","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1476-5381.2010.00773.x","article-title":"Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington\u2019s disease","volume":"160","author":"Scotter","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0790","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/jcp.29949","article-title":"Virodhamine, an endocannabinoid, induces megakaryocyte differentiation by regulating MAPK activity and function of mitochondria","volume":"236","author":"Sharma","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0795","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0167-4781(96)00047-4","article-title":"Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor","volume":"1307","author":"Shire","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.jneuroim.2021.577501_bb0800","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/molecules24081459","article-title":"Use of cannabidiol in the treatment of epilepsy: efficacy and security in clinical trials","volume":"24","author":"Silvestro","year":"2019","journal-title":"Mol. (Basel, Switzerland)"},{"issue":"10055","key":"10.1016\/j.jneuroim.2021.577501_bb0805","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet (Lond. Engl.)"},{"issue":"11","key":"10.1016\/j.jneuroim.2021.577501_bb0810","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1535-7163.MCT-13-0486","article-title":"The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells","volume":"12","author":"Sreevalsan","year":"2013","journal-title":"Mol. Cancer Therapeutics"},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0815","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/can.2017.0002","article-title":"Cannabinoids in Parkinson's disease","volume":"2","author":"Stampanoni Bassi","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"issue":"7034","key":"10.1016\/j.jneuroim.2021.577501_bb0820","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0825","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1074\/jbc.275.1.605","article-title":"Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells","volume":"275","author":"Sugiura","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0830","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00726-012-1252-8","article-title":"The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease","volume":"45","author":"Tanasescu","year":"2013","journal-title":"Amino Acids"},{"issue":"10","key":"10.1016\/j.jneuroim.2021.577501_bb0835","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1348-0421.2007.tb03985.x","article-title":"Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice","volume":"51","author":"Tanikawa","year":"2007","journal-title":"Microbiol. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0840","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuron.2010.01.021","article-title":"The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission","volume":"65","author":"Tanimura","year":"2010","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jneuroim.2021.577501_bb0845","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41398-020-0832-8","article-title":"Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia","volume":"10","author":"Tao","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"11","key":"10.1016\/j.jneuroim.2021.577501_bb0850","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048272","article-title":"Regulation of MMP-9 by a WIN-binding site in the monocyte-macrophage system independent from cannabinoid receptors","volume":"7","author":"Tauber","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577501_bb0860","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V49.5.671.671","article-title":"Current status of bone marrow transplantation for aplastic anemia and acute leukemia","volume":"49","author":"Thomas","year":"1977","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jneuroim.2021.577501_bb0865","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjp.0706414","article-title":"Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist","volume":"146","author":"Thomas","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.jneuroim.2021.577501_bb0870","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.jneuroim.2021.577501_bb0875","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1189\/jlb.3RU0115-021R","article-title":"Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites","volume":"97","author":"Turcotte","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577501_bb0880","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1677\/JME-08-0190","article-title":"Signal transduction of the CB1 cannabinoid receptor","volume":"44","author":"Turu","year":"2010","journal-title":"J. Mol. Endocrinol."},{"issue":"9","key":"10.1016\/j.jneuroim.2021.577501_bb0885","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12997","article-title":"Adipokine dysregulation and adipose tissue inflammation in human obesity","volume":"48","author":"Unamuno","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jneuroim.2021.577501_bb0890","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejphar.2018.11.029","article-title":"Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma","volume":"843","author":"Vuolo","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2021.577501_bb0895","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2826.2008.01672.x","article-title":"Endocannabinoids and the brain immune system: new neurones at the horizon?","volume":"20","author":"Wolf","year":"2008","journal-title":"J. Neuroendocrinol."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0905","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1189\/jlb.0307159","article-title":"Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis","volume":"82","author":"Xu","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.jneuroim.2021.577501_bb0910","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.3892\/etm.2016.3818","article-title":"\u03b2-Caryophyllene promotes osteoblastic mineralization, and suppresses osteoclastogenesis and adipogenesis in mouse bone marrow cultures in vitro","volume":"12","author":"Yamaguchi","year":"2016","journal-title":"Exp. Therapeutic Med."},{"issue":"36","key":"10.1016\/j.jneuroim.2021.577501_bb0915","doi-asserted-by":"crossref","first-page":"31532","DOI":"10.1074\/jbc.M111.237990","article-title":"Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals","volume":"286","author":"Yang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0920","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1874467212666190215112036","article-title":"New insights in cannabinoid receptor structure and signaling","volume":"12","author":"Ye","year":"2019","journal-title":"Curr. Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.jneuroim.2021.577501_bb0925","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.bbmt.2015.05.018","article-title":"Cannabidiol for the prevention of graft-versus-host-disease after allogeneic hematopoietic cell transplantation: results of a phase II study","volume":"21","author":"Yeshurun","year":"2015","journal-title":"Biol. Blood Marrow Transplant.: J. Am. Soc. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.jneuroim.2021.577501_bb0930","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.3390\/ijms21114177","article-title":"Calcium entry through TRPV1: a potential target for the regulation of proliferation and apoptosis in cancerous and healthy cells","volume":"21","author":"Zhai","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577501_bb0935","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/FJC.0b013e3181d2644d","article-title":"Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules","volume":"55","author":"Zhao","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"9","key":"10.1016\/j.jneuroim.2021.577501_bb0940","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00251-006-0138-x","article-title":"Formation of B and T cell subsets require the cannabinoid receptor CB2","volume":"58","author":"Ziring","year":"2006","journal-title":"Immunogenetics"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282100028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282100028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:38:36Z","timestamp":1759048716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557282100028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":177,"alternative-id":["S016557282100028X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577501","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577501"}}